Skip to main content
Fig. 5 | BMC Cardiovascular Disorders

Fig. 5

From: Intermittent concurrent use of clopidogrel and proton pump inhibitors did not increase risk of adverse clinical outcomes in Chinese patients with coronary artery disease

Fig. 5

Comparison of the risk of MACE after 18 months among sustained PPI, intermittent PPI and non-PPI users. a Proportion of MACE after 18 months in sustained PPI, intermittent PPI and non-PPI users. b Kaplan–Meier survival curves representing the estimated cumulative incidence of MACE after 18 months in sustained PPI, intermittent PPI and non-PPI users. MI, myocardial infarction; MACE, Major adverse cardiac events; PPI, proton pump inhibitor

Back to article page